tiprankstipranks
Advertisement
Advertisement

MDGL Stock Latest News

Madrigal Shareholders Approve 2026 Equity Compensation Plans
Company AnnouncementsMadrigal Shareholders Approve 2026 Equity Compensation Plans
4d ago
8K
MDGL
Madrigal Pharmaceuticals management to meet with Piper Sandler
PremiumThe Fly
Madrigal Pharmaceuticals management to meet with Piper Sandler
4d ago
MDGL
Madrigal Pharmaceuticals price target lowered to $542 from $550 at BofA
PremiumThe Fly
Madrigal Pharmaceuticals price target lowered to $542 from $550 at BofA
10d ago
MDGL
Analyst Reiterates Buy on Madrigal Pharmaceuticals, Maintains $620 Price Target on Strengthened Rezdiffra MASH and Cardiometabolic Data
PremiumRatings
Analyst Reiterates Buy on Madrigal Pharmaceuticals, Maintains $620 Price Target on Strengthened Rezdiffra MASH and Cardiometabolic Data
24d ago
MDGL
Madrigal Pharmaceuticals announces new analyses of Rezdiffra data
PremiumThe Fly
Madrigal Pharmaceuticals announces new analyses of Rezdiffra data
25d ago
MDGL
Madrigal’s Rezdiffra Drives Blockbuster Growth Amid Costs
PremiumCompany AnnouncementsMadrigal’s Rezdiffra Drives Blockbuster Growth Amid Costs
1M ago
MDGL
Paulson takes new stake in Amicus, cuts position in Madrigal Pharma
Premium
The Fly
Paulson takes new stake in Amicus, cuts position in Madrigal Pharma
1M ago
BHC
Madrigal Pharmaceuticals price target raised to $709 from $640 at Truist
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $709 from $640 at Truist
1M ago
MDGL
Madrigal Pharmaceuticals price target lowered to $578 from $587 at Canaccord
PremiumThe Fly
Madrigal Pharmaceuticals price target lowered to $578 from $587 at Canaccord
1M ago
MDGL
Madrigal Pharmaceuticals price target lowered to $649 from $652 at Evercore ISI
PremiumThe Fly
Madrigal Pharmaceuticals price target lowered to $649 from $652 at Evercore ISI
2M ago
MDGL
Madrigal Pharmaceuticals reports Q1 EPS ($3.25), consensus ($4.14)
PremiumThe Fly
Madrigal Pharmaceuticals reports Q1 EPS ($3.25), consensus ($4.14)
2M ago
MDGL
Madrigal Earnings Call: Rezdiffra Boom, Profits Delayed
PremiumCompany Announcements
Madrigal Earnings Call: Rezdiffra Boom, Profits Delayed
2M ago
MDGL
Madrigal Pharmaceuticals price target raised to $680 from $533 at Clear Street
PremiumThe FlyMadrigal Pharmaceuticals price target raised to $680 from $533 at Clear Street
2M ago
MDGL
Arrowhead announces exclusive worldwide license agreement with Madrigal Pharma
Premium
The Fly
Arrowhead announces exclusive worldwide license agreement with Madrigal Pharma
2M ago
ARWR
MDGL
MDGL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MDGL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
MDGL
Madrigal Expands Resmetirom Reach With New Post-Transplant MASH Trial
PremiumCompany Announcements
Madrigal Expands Resmetirom Reach With New Post-Transplant MASH Trial
2M ago
MDGL
Madrigal Pharmaceuticals Reclassifies Board Ahead of 2026 Meeting
PremiumCompany Announcements
Madrigal Pharmaceuticals Reclassifies Board Ahead of 2026 Meeting
2M ago
8K
MDGL
Ritu Baral Reaffirms Buy on Madrigal Pharmaceuticals Following Updated Financial Model and Sustained Long-Term Upside Outlook
PremiumRatings
Ritu Baral Reaffirms Buy on Madrigal Pharmaceuticals Following Updated Financial Model and Sustained Long-Term Upside Outlook
2M ago
MDGL
Madrigal Pharmaceuticals off highs, remains up 13% in afternoon trading
PremiumThe Fly
Madrigal Pharmaceuticals off highs, remains up 13% in afternoon trading
3M ago
MDGL
Madrigal’s Rezdiffra Drives Blockbuster‑Level First Year
PremiumCompany AnnouncementsMadrigal’s Rezdiffra Drives Blockbuster‑Level First Year
4M ago
MDGL
Madrigal Pharmaceuticals price target lowered to $529 from $570 at BofA
Premium
The Fly
Madrigal Pharmaceuticals price target lowered to $529 from $570 at BofA
4M ago
MDGL
Madrigal Pharmaceuticals: Rezdiffra’s Strong Launch, Expanding Prescriber Adoption, and Advancing Pipeline Underpin Buy Rating
Premium
Ratings
Madrigal Pharmaceuticals: Rezdiffra’s Strong Launch, Expanding Prescriber Adoption, and Advancing Pipeline Underpin Buy Rating
4M ago
MDGL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >